Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-024049
Filing Date
2017-07-10
Accepted
2017-07-10 15:52:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 97133
  Complete submission text file 0000000000-17-024049.txt   134505
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filed for) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations